A tumor found in the bladder is not always cancerous. While the majority of bladder tumors do turn out to be malignant, a meaningful minority are benign growths, inflammatory masses, or other non-cancerous conditions that can look alarmingly similar to cancer on imaging and even during cystoscopy. The distinction matters enormously for treatment and prognosis, but it almost always requires a tissue sample to settle.
How Often Bladder Tumors Turn Out to Be Benign
Most bladder masses are malignant, which is why urologists treat every new finding with urgency. But “most” is not “all.” In a review of over 1,600 transurethral resections of bladder tumors (the standard procedure for removing and diagnosing bladder growths), about 17% of the resected specimens came back as benign on pathology.1Kosin Medical Journal. Comparison of the prevalence and histology between primary benign bladder tumors and recurrent benign lesions after transurethral resection of malignant bladder tumors That is roughly one in six cases. Among the benign findings, the single most common diagnosis was cystitis, an inflammatory condition rather than a true tumor. This tells you something important: not every mass-like abnormality inside the bladder is even a growth in the usual sense. Some are the body’s inflammatory response to chronic irritation.
The rate of benign findings was even higher among patients who had already been treated for a previous bladder cancer and came back for surveillance. In that group, over a quarter of the newly resected lesions turned out to be benign. That can be reassuring if you are in follow-up and a new spot appears on cystoscopy, though it does not eliminate the need to biopsy it.
Truly Benign Bladder Tumors
Several types of genuine tumors can grow inside the bladder without being cancerous. They are uncommon individually, but collectively they make up a recognizable share of bladder pathology.
Leiomyoma
A leiomyoma is a smooth-muscle tumor, essentially the same kind of growth as a uterine fibroid but arising in the bladder wall instead. These are non-infiltrative, show no abnormal cell division under the microscope, and almost never recur after surgical removal.2PubMed Central. Bladder leiomyoma: Presentation, evaluation and treatment People with bladder leiomyomas tend to show up with urinary symptoms like difficulty emptying the bladder or frequent urges, and about a quarter have blood in the urine.3PubMed Central. Characteristics and outcomes in bladder Leiomyoma management: a systematic review of case reports and case series from the past 20 years Roughly one in six cases are discovered incidentally during imaging for something else entirely. The left lateral wall and bladder neck are the most common locations. Treatment is straightforward: surgical removal, often through the same transurethral approach used for cancer, and recurrence is vanishingly rare.
Inverted Papilloma
An inverted papilloma is a benign growth of the urothelial cells that line the bladder. Unlike a typical papillary tumor that grows outward into the bladder cavity on a stalk, an inverted papilloma grows inward, pushing into the deeper tissue layers without actually invading them. Diagnosis depends on what the pathologist sees under the microscope: the cells look uniform and orderly, without the chaotic features of cancer.4PubMed Central. Inverted papilloma of the bladder: a very rare benign lesion with malignant implications – case report and comprehensive literature review When diagnosed according to strict criteria, inverted papillomas recur only about 1% of the time and carry an excellent prognosis.5PubMed. Natural history of urothelial inverted papilloma The catch is that some bladder cancers can have inverted-growth patterns too, so the pathologist needs to be precise about the diagnosis.
Paraganglioma
This is one of the more dramatic benign bladder tumors. A paraganglioma arises from nerve-related cells in the bladder wall and can secrete stress hormones like norepinephrine.6American Journal of Case Reports. Urinary Bladder Paraganglioma presenting as Micturition-Induced Palpitations, Dyspnea, and Angina The result is a bizarre set of symptoms: blood pressure spikes, pounding heartbeat, headaches, and even chest pain triggered by urination. They most often sit on the trigone, the triangular area at the base of the bladder. Some paragangliomas are “non-functioning,” meaning they do not release enough hormones to cause these classic attacks, which makes them harder to suspect before surgery.7PubMed Central. Non-functioning paraganglioma occurring in the urinary bladder: A case report and review of the literature. While most bladder paragangliomas behave in a benign fashion, a small percentage can be malignant, so follow-up is important.
Inflammatory Masses That Mimic Cancer
Some of the most confusing bladder “tumors” are not tumors at all. They are inflammatory or reactive processes that produce a mass visible on imaging or cystoscopy, fooling clinicians into suspecting cancer until the tissue is examined.
Malakoplakia
Malakoplakia is a rare granulomatous condition that most commonly affects the urinary tract, with the bladder as its favorite target. It creates plaque-like or nodular lesions that look worrisome on imaging and at cystoscopy, closely mimicking malignancy.8PubMed Central. Recurrent bladder malakoplakia: A rare bladder lesion mimicking malignancy The condition is thought to result from a defective immune response to bacterial infections, particularly in immunosuppressed individuals. One case report documented malakoplakia involving both the ureter and bladder that clinically mimicked urothelial carcinoma so convincingly that only biopsy settled the question.9BJR|Case Reports. Ureter and bladder malakoplakia: a case report
Cystitis Glandularis and Cystitis Cystica
Chronic bladder irritation, whether from repeated infections, catheters, or stones, can trigger the bladder lining to change in ways that produce mass-like lesions. Cystitis glandularis is a proliferative change in the bladder mucosa driven by ongoing inflammation.10Radiology Case Reports. Cystitis glandularis mimicking a bladder tumor: A rare case report It frequently coexists with a related condition called cystitis cystica, and both are benign mimics of invasive bladder cancer.11Journal of Clinical Research and Reports. Cystitis Cystica and Cystitis Glandularis of the Urinary Bladder: A Review and Update They can form polypoid or nodular growths that, on cystoscopy, are essentially indistinguishable from a true tumor. Treating the underlying irritation often resolves the lesions.
Inflammatory Myofibroblastic Tumor
An inflammatory myofibroblastic tumor is a rare bladder mass made up of proliferating spindle-shaped cells mixed with immune cells. It has a pseudosarcomatous appearance, meaning it can look under the microscope as if it might be a sarcoma, a type of cancer.12PubMed Central. Inflammatory myofibroblastic tumor of the urinary bladder Despite that alarming appearance, these tumors are considered benign, though their long-term behavior is not perfectly understood and they are sometimes described as having uncertain malignant potential. Surgical removal is usually curative.
Endometriosis in the Bladder
Women of reproductive age can develop endometrial tissue implants on or within the bladder wall. Bladder endometriosis is uncommon but well recognized, and it creates a focal mass that on ultrasound or CT can look exactly like a bladder tumor.13PubMed Central. Bladder Endometriosis Masquerading as Bladder Tumor: The Role of Magnetic Resonance Imaging in Diagnosis A classic clue is cyclical symptoms that track with menstruation: urgency, blood in the urine, and lower abdominal pain that worsens around the time of a period.14PubMed Central. A rare cyclic recurrent hematuria case; bladder endometriosis Not every patient has such textbook timing, though, and some are found incidentally when imaging is done for unrelated reasons. The condition is entirely benign in the oncological sense, though it can cause significant symptoms and may require surgical treatment.
Infections That Create Bladder Masses
In certain parts of the world, the parasitic infection schistosomiasis (caused by the blood fluke Schistosoma haematobium) is a well-known cause of bladder lesions. The parasites deposit eggs in the bladder wall, triggering intense inflammation that can produce a pedunculated (stalk-like) mass visible on imaging.15PubMed Central. Urinary Bladder Schistosomiasis Mimicking Neoplasm: A Case Report In a person who has traveled to or lived in endemic areas of sub-Saharan Africa, the Middle East, or parts of Southeast Asia, schistosomiasis should be on the list of possibilities when a bladder mass turns up. Confusingly, chronic schistosomiasis is also a genuine risk factor for developing bladder cancer (specifically squamous cell carcinoma), so even when the infection is confirmed, tissue sampling is still needed to rule out a malignancy that has developed alongside the parasitic damage.
The Gray Zone Between Benign and Malignant
Not every bladder growth falls neatly into “cancer” or “not cancer.” A category called papillary urothelial neoplasm of low malignant potential, or PUNLMP, sits in a gray area. These are papillary growths of the bladder lining that look abnormal but do not meet the full criteria for cancer. At five years, about 21% of PUNLMP patients had a local recurrence, compared to roughly 42% of patients with low-grade papillary carcinoma.16PubMed. Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study Progression to muscle-invasive disease was rare in both groups but even rarer with PUNLMP, under 1% at five years in that study.
A separate analysis found that PUNLMP patients had better five-year recurrence-free survival (about 75%) than those with low-grade carcinoma (about 50%), though the two groups did not differ significantly in terms of actual disease progression.17PubMed Central. Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC) In practical terms, a PUNLMP diagnosis is better news than a cancer diagnosis, but it is not a clean bill of health. You still need regular surveillance cystoscopies, because these growths can come back and, on rare occasions, the recurrent lesion can be upgraded to carcinoma.
Why Symptoms Alone Cannot Tell You
The frustrating reality is that benign and malignant bladder masses share the same presenting symptoms. Blood in the urine is the hallmark complaint for bladder cancer, but it also appears with leiomyomas, endometriosis, malakoplakia, and inflammatory conditions. One case report documented a patient with gross hematuria and irritative urinary symptoms whose presentation was initially “primarily worrisome for malignancy,” yet turned out to be a combination of two benign conditions: nephrogenic adenoma and eosinophilic cystitis.18Bladder. Gross hematuria, irritative lower urinary tract symptoms, and bilateral hydroureteronephrosis: A concerning presentation of an ultimately benign case of concurrent nephrogenic adenoma and eosinophilic cystitis Frequency, urgency, and pelvic pain are similarly nonspecific. No combination of symptoms reliably distinguishes a benign bladder mass from cancer, which is exactly why biopsy remains the standard.
How Doctors Figure Out What a Bladder Mass Actually Is
The gold standard for diagnosing any bladder mass is cystoscopy with tissue sampling. In most cases that means transurethral resection of the bladder tumor (TURBT), a procedure that both removes the visible growth and provides tissue for the pathologist to examine under the microscope. Histopathological examination after resection is the confirmatory test.19Open Access Journal of Urology & Nephrology. Clinical Predictors of Histological Grade of Urothelial Carcinoma of Urinary Bladder before First-Time Transurethral Resection of the Bladder Tumor (Turbt) No imaging study, blood test, or urine marker can definitively replace the pathologist’s verdict.
That said, imaging plays a growing role in pre-operative planning. Multiparametric MRI of the bladder, scored using a system called VI-RADS, has become a valuable tool for assessing whether a tumor invades the muscle layer of the bladder wall, a critical distinction that determines treatment.20PubMed. Multiparametric MRI for Bladder Cancer: A Practical Approach to the Clinical Application of VI-RADS In prospective testing, the VI-RADS system achieved around 88% sensitivity and 88% specificity for detecting muscle-invasive disease.21PubMed Central. Prospective assessment of VI-RADS score in multiparametric MRI in bladder cancer: accuracy and the factors affecting the results MRI cannot tell you whether a mass is benign or malignant with certainty, but it can help the surgical team plan the right operation by estimating the depth of involvement.
Urine-based tests offer a less invasive complement. Urine cytology, where a pathologist looks for abnormal cells shed into the urine, is highly specific but not very sensitive, meaning it catches cancer when it finds abnormal cells but misses many cases. Newer markers like Nuclear Matrix Protein 22 (NMP22) show better sensitivity, detecting about three-quarters of cancers in one study compared to roughly a third for cytology.22JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. Assessment of Diagnostic Accuracy of Nuclear Matrix Protein 22 versus Urine Cytology for Detecting Bladder Cancer keeping Cystoscopy and Biopsy as Gold Standard: A Cross-sectional Study These urine tests are useful as supplements, particularly for surveillance after a previous cancer, but they are not recommended as standalone screening tools for the general population because bladder cancer is relatively uncommon.23PubMed Central. Review of non-invasive urinary biomarkers in bladder cancer
What Happens When a Tumor Near the Ureteral Opening Needs Removal
A practical concern that comes up during TURBT is what to do when a tumor sits close to one of the ureteral orifices, the openings where the ureters drain urine from the kidneys into the bladder. Aggressive cauterization near these spots can cause scarring and block the ureter, potentially harming kidney function. Surgeons can resect tumors in this location carefully using pure cutting settings rather than heavy coagulation, sometimes placing a temporary ureteral stent for a few weeks afterward to keep the channel open.24PubMed Central. Transurethral resection of bladder tumour (TURBT) Preserving kidney function matters especially in cases where the tumor turns out to be malignant and the patient may need chemotherapy that requires good renal function.
Bladder Masses in Children
Bladder tumors in children are rare, and when they do occur, the picture looks quite different from adults. In adults, the vast majority of bladder tumors arise from the urothelial lining. In children, mesenchymal tumors, those arising from connective or muscle tissue, are actually more common than urothelial ones.25PubMed. Pearls and Pitfalls in Diagnosing Pediatric Urinary Bladder Masses The most well-known pediatric bladder tumor is rhabdomyosarcoma, which is malignant and requires aggressive treatment. But benign pediatric bladder masses also exist, including fibromas and inflammatory polyps. Because the underlying biology and spectrum of diagnoses are so different in children, pediatric bladder masses call for evaluation by specialists familiar with these patterns rather than applying adult bladder cancer protocols.